← Back to Bills
HR 8223118th CongressFailed / ExpiredHouse

Advancing Menopause Care and Mid-Life Women’s Health Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
May 27, 2025
Latest Action Date
May 10, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Advancing Menopause Care and Mid-Life Women’s Health Act (H.R. 8223) is a legislative proposal introduced in the 118th Congress aimed at improving healthcare services and support for menopause and mid-life women's health. The bill was referred to the House Subcommittee on Health but did not advance further and ultimately failed or expired. Specific provisions, funding mechanisms, or detailed policy measures are not available in the provided source data.

Bottom Line

H.R. 8223 sought to address healthcare needs related to menopause and mid-life women's health but did not progress beyond subcommittee referral and expired without enactment.

Policy Risk Level
🟢 Low
Neutral Risk Assessment
Key Points
  • The bill focuses on advancing care and health services for menopause and mid-life women.
  • It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
  • The bill did not pass and is currently classified as failed or expired.
Who Benefits?

['Mid-life women experiencing menopause', "Healthcare providers specializing in women's health", "Health agencies involved in women's health programs"]

Potential Concerns

['Lack of detailed information on funding and implementation strategies limits assessment of feasibility.', 'Absence of oversight or enforcement language in the available data may affect accountability.', 'The bill’s failure to advance suggests potential challenges in legislative support or prioritization.']

Political Context

The bill was introduced in the House of Representatives during the 118th Congress and referred to the Subcommittee on Health. It did not progress beyond this stage and expired, indicating it did not receive sufficient legislative momentum or prioritization within the congressional session.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

["Potential increased awareness and prioritization of menopause and mid-life women's health issues in future legislative efforts.", 'Possible influence on healthcare providers to consider menopause-related care improvements even without legislative mandate.', "Encouragement for advocacy groups to push for renewed legislative attention on mid-life women's health."]

GovScope Watchdog Notes

The absence of the full bill text and official summary limits transparency and comprehensive analysis. The bill’s failure to advance past subcommittee referral suggests limited legislative support during the 118th Congress. Future tracking would benefit from access to complete legislative documents and detailed summaries to better assess policy implications and oversight needs.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready